2025 annual financial data
Atara Biotherapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -42.18%.
Operating income was 35,862,000 USD and net income was 32,688,000 USD.
Operating cash flow was -50,940,000 USD.
Get free Atara Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 120,772,000 USD
- Operating income
- 35,862,000 USD
- Net income
- 32,688,000 USD
- Operating cash flow
- -50,940,000 USD